CareMax Inc (NASDAQ: CMAX) stock jumped 0.99% on Friday to $0.95 against a previous-day closing price of $0.94. With 0.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.27 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $1.0000 whereas the lowest price it dropped to was $0.9400. The 52-week range on CMAX shows that it touched its highest point at $5.18 and its lowest point at $0.91 during that stretch. It currently has a 1-year price target of $4.00. Beta for the stock currently stands at 1.27.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CMAX was down-trending over the past week, with a drop of -24.30%, but this was down by -57.96% over a month. Three-month performance dropped to -52.74% while six-month performance fell -66.78%. The stock lost -81.11% in the past year, while it has lost -73.97% so far this year. A look at the trailing 12-month EPS for CMAX yields -1.84 with Next year EPS estimates of -0.60. For the next quarter, that number is -0.13. This implies an EPS growth rate of -346.50% for this year and 67.61% for next year.

Float and Shares Shorts:

At present, 111.33 million CMAX shares are outstanding with a float of 67.90 million shares on hand for trading. On Oct 30, 2023, short shares totaled 7.9 million, which was 7.05% higher than short shares on Sep 28, 2023. In addition to CMA as the firm’s Comerica Incorporated, CMRX serves as its Chimerix, Inc..

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CMAX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CMAX analysts setting a high price target of $10.00 and a low target of $1.00, the average target price over the next 12 months is $4.00. Based on these targets, CMAX could surge 952.63% to reach the target high and rise by 5.26% to reach the target low. Reaching the average price target will result in a growth of 321.05% from current levels.

Summary of Insider Activity:

Insiders traded CMAX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 12 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 185,593 while 0 shares were sold.

Leave a Reply

Your email address will not be published. Required fields are marked *